sitaxsentan Size:Solid 10 mg Heterogeneous ceramide distributions alter spatially

Heterogeneous ceramide distributions alter spatially resolved growth of Staphylococcus aureus on human stratum corneum

(2015) J Med Chem

InChi: InChI=1S/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7

1'-biphenyl]-3-yl]methoxy}phenyl)hex-4-ynoic acid

methyl (1R

sitaxsentan Size:Solid 10 mg Heterogeneous ceramide distributions alter spatiallySitaxentan, also known as TBC 11251 and IPI 1040, is a medication for the treatment of pulmonary arterial hypertension (PAH). It was marketed as Thelin. In 2010, Pfizer voluntarily removed sitaxentan from the market due to concerns about liver toxicity. Sitaxentan is a small molecule that blocks the action of endothelin (ET) on the endothelin A (ETA) receptor selectively (by a factor of 6000 compared with the ETB). Product information CAS Number: